市场消息:美国食品药品管理局(FDA)批准首个用于治疗低血糖的GLP-1仿制药;批准首个提及VICTOZA的仿制药。 适

美港电讯
24 Dec 2024

市场消息:美国食品药品管理局(FDA)批准首个用于治疗低血糖的GLP-1仿制药;批准首个提及VICTOZA的仿制药。 适用于改善糖尿病患者的血糖控制。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10